BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

443 related articles for article (PubMed ID: 27894707)

  • 1. Missteps in Current Estimates of Cancer Overdiagnosis.
    Lee CI; Etzioni R
    Acad Radiol; 2017 Feb; 24(2):226-229. PubMed ID: 27894707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breast cancer incidence trends in Norway and estimates of overdiagnosis.
    van Luijt PA; Heijnsdijk EA; van Ravesteyn NT; Hofvind S; de Koning HJ
    J Med Screen; 2017 Jun; 24(2):83-91. PubMed ID: 27754936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extrapolation of pre-screening trends: Impact of assumptions on overdiagnosis estimates by mammographic screening.
    Ripping TM; Verbeek AL; Ten Haaf K; van Ravesteyn NT; Broeders MJ
    Cancer Epidemiol; 2016 Jun; 42():147-53. PubMed ID: 27153471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How Can Advanced Imaging Be Used to Mitigate Potential Breast Cancer Overdiagnosis?
    Rahbar H; McDonald ES; Lee JM; Partridge SC; Lee CI
    Acad Radiol; 2016 Jun; 23(6):768-73. PubMed ID: 27017136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mammography screening: A major issue in medicine.
    Autier P; Boniol M
    Eur J Cancer; 2018 Feb; 90():34-62. PubMed ID: 29272783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Discrepancies and overdiagnosis in breast cancer organized screening. A "methodology" systematic review].
    Gocko X; Leclerq M; Plotton C
    Rev Epidemiol Sante Publique; 2018 Nov; 66(6):395-403. PubMed ID: 30316554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimation of overdiagnosis using short-term trends and lead time estimates uncontaminated by overdiagnosed cases: Results from the Norwegian Breast Screening Programme.
    Michalopoulos D; Duffy SW
    J Med Screen; 2016 Dec; 23(4):192-202. PubMed ID: 26940963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A reality check for overdiagnosis estimates associated with breast cancer screening.
    Etzioni R; Xia J; Hubbard R; Weiss NS; Gulati R
    J Natl Cancer Inst; 2014 Dec; 106(12):. PubMed ID: 25362701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recognizing the Limitations of Cancer Overdiagnosis Studies: A First Step Towards Overcoming Them.
    Etzioni R; Gulati R
    J Natl Cancer Inst; 2016 Mar; 108(3):. PubMed ID: 26582245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overdiagnosis associated with breast cancer screening: A simulation study to compare lead-time adjustment methods.
    Seigneurin A; Labarère J; Duffy SW; Colonna M
    Cancer Epidemiol; 2015 Dec; 39(6):1128-35. PubMed ID: 26341587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimation of overdiagnosis by detection to incidence ratio in cancer screening.
    Hakama M; Malila N
    J Med Screen; 2019 Sep; 26(3):135-138. PubMed ID: 30987504
    [No Abstract]   [Full Text] [Related]  

  • 12. Current Issues in the Overdiagnosis and Overtreatment of Breast Cancer.
    Monticciolo DL; Helvie MA; Hendrick RE
    AJR Am J Roentgenol; 2018 Feb; 210(2):285-291. PubMed ID: 29091010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overdiagnosis and overtreatment associated with breast cancer mammography screening: A simulation study with calibration to population-based data.
    Seigneurin A; Labarère J; François O; Exbrayat C; Dupouy M; Filippi M; Colonna M
    Breast; 2016 Aug; 28():60-6. PubMed ID: 27240167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overdiagnosis and overtreatment of breast cancer: estimates of overdiagnosis from two trials of mammographic screening for breast cancer.
    Duffy SW; Agbaje O; Tabar L; Vitak B; Bjurstam N; Björneld L; Myles JP; Warwick J
    Breast Cancer Res; 2005; 7(6):258-65. PubMed ID: 16457701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantifying Overdiagnosis in Cancer Screening: A Systematic Review to Evaluate the Methodology.
    Ripping TM; Ten Haaf K; Verbeek ALM; van Ravesteyn NT; Broeders MJM
    J Natl Cancer Inst; 2017 Oct; 109(10):. PubMed ID: 29117353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breast, prostate, and thyroid cancer screening tests and overdiagnosis.
    Jung M
    Curr Probl Cancer; 2017; 41(1):71-79. PubMed ID: 28104314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Missteps in Estimates of Cancer Overdiagnosis.
    Bleyer A
    Acad Radiol; 2017 Apr; 24(4):516-517. PubMed ID: 28189504
    [No Abstract]   [Full Text] [Related]  

  • 18. The balance sheet of benefits and harms of breast cancer population-based screening in Europe: outcome research, practice and future challenges.
    Broeders M; Paci E
    Womens Health (Lond); 2015 Nov; 11(6):883-90. PubMed ID: 26619214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implications of Overdiagnosis: Impact on Screening Mammography Practices.
    Morris E; Feig SA; Drexler M; Lehman C
    Popul Health Manag; 2015 Sep; 18 Suppl 1(Suppl 1):S3-11. PubMed ID: 26414384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. As you like it: How the same data can support manifold views of overdiagnosis in breast cancer screening.
    Njor SH; Paci E; Rebolj M
    Int J Cancer; 2018 Sep; 143(6):1287-1294. PubMed ID: 29633249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.